Role of eicosanoids and related mediators in gastric mucosal ulceration.
Whittle
B J
BJ
Department of Pharmacology, Wellcome Research Laboratories, Beckenham, Kent, U.K.
D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D015064:16,16-Dimethylprostaglandin E2 / Q000494:pharmacology; D000818:Animals; D015777:Eicosanoids / Q000502:physiology*; D005753:Gastric Mucosa / Q000187:drug effects / Q000473:pathology; D006861:Hydrogen Peroxide / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008297:Male; D011450:Prostaglandin Endoperoxides, Synthetic / Q000037:antagonists & inhibitors; D051381:Rats; D013270:Stomach / Q000473:pathology; D013276:Stomach Ulcer / Q000139:chemically induced* / Q000473:pathology; D013449:Sulfonamides / Q000494:pharmacology
D015777:Eicosanoids; D011450:Prostaglandin Endoperoxides, Synthetic; D013449:Sulfonamides; C040624:sulotroban; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D006861:Hydrogen Peroxide; D015064:16,16-Dimethylprostaglandin E2